Skip to main content

MSN Writing Services

NURS FPX 4025 Assessment 3

New Samples

Struggling With Your Assessments? Get Help From Our Tutors

    NURS FPX 4025 Assessment 3

    NURS FPX 4025 Assessment 3

    Student Name

    Capella University

    NURS-FPX4025 Research and Evidence-Based Decision Making

    Prof. Name

    Date

    Chronic Obstructive Pulmonary Disease (COPD) and Smoking Cessation

    Understanding COPD and Its Challenges

    Chronic Obstructive Pulmonary Disease (COPD) is a severe lung condition that makes breathing difficult. Smoking is a primary cause, and quitting can slow disease progression. However, many patients struggle to quit due to nicotine addiction and lack of support. COPD is among the top ten causes of death in the U.S., affecting approximately 16 million adults (Centers for Disease Control and Prevention [CDC], 2024).

    COPD symptoms include persistent coughing, shortness of breath, and frequent lung infections. If not managed well, it can worsen over time, leading to hospitalizations, heart problems, or even respiratory failure. Quitting smoking is the best way to control the disease, yet many patients find it challenging due to stress, addiction, or limited access to healthcare (American Lung Association [ALA], 2024).

    NURS FPX 4025 Assessment 3

    Certain groups face additional challenges in managing COPD. Older adults, low-income individuals, and those with limited healthcare access are particularly vulnerable (Alupo et al., 2024). Financial constraints prevent some patients from affording inhalers, oxygen therapy, or frequent doctor visits. Limited access to healthcare services increases their risk of severe complications and hospitalizations. Nurses play a crucial role in educating and supporting these patients, ensuring they receive the care they need (Wang et al., 2024).

    Research Question and PICO(T) Framework

    Importance of Smoking Cessation for COPD Patients

    Quitting smoking is essential for slowing COPD progression and improving overall health. However, many patients struggle to quit without structured support. This assessment evaluates whether structured smoking cessation programs are more effective than standard counseling in helping COPD patients quit smoking and improve lung function.

    Formulating the Research Question

    A well-defined research question is crucial in identifying the most effective intervention (Gosak et al., 2024). Using the PICO(T) method, the research question is:

    In adult patients diagnosed with COPD (P), how does a structured smoking cessation program incorporating behavioral counseling and pharmacotherapy (I) compared to standard smoking cessation counseling (C) affect the smoking cessation rates and pulmonary function (O) within six months (T)?

    Breakdown of the PICO(T) Criteria

    • Population (P): Adults diagnosed with COPD. Smoking cessation is a key factor in managing their disease.
    • Intervention (I): A structured smoking cessation program that includes behavioral counseling and pharmacotherapy (e.g., nicotine replacement therapy, varenicline, or bupropion). Multi-component programs have shown higher quit rates (Fu et al., 2022).
    • Comparison (C): Standard smoking cessation counseling, which may involve brief discussions or educational materials.
    • Outcome (O): Smoking cessation rates and improved lung function over time.
    • Time (T): Six months, as research suggests that maintaining smoking cessation beyond this period increases the likelihood of long-term abstinence (Hu et al., 2021).

    NURS FPX 4025 Assessment 3

    This study is particularly relevant to populations with fewer healthcare resources. Comparing structured programs to standard counseling will help determine the best method for long-term smoking cessation. The findings will aid nurses in providing better patient support and improving COPD management.

    Literature Review and Evidence Analysis

    Research Strategy and Source Selection

    A systematic search was conducted across PubMed, CINAHL, Cochrane Library, and Google Scholar to gather relevant evidence on smoking cessation for COPD patients. Keywords included “COPD,” “smoking cessation,” “nicotine replacement therapy,” “behavioral counseling,” “pharmacotherapy,” and “pulmonary rehabilitation.” Boolean operators (AND, OR) refined the search, ensuring the studies focused specifically on COPD patients.

    Studies were assessed using the CRAAP criteria (Currency, Relevance, Authority, Accuracy, and Purpose) to ensure credibility. Peer-reviewed journal articles, systematic reviews, and meta-analyses from the past five years were prioritized. Reputable sources such as the CDC and ALA were included to ensure clinical relevance. The search was further refined using filters for full-text availability, English-language publications, and studies focused on adult COPD patients.

    Key Findings from the Literature

    The Impact of Smoking Cessation on COPD

    Wang et al. (2024) conducted a meta-analysis of 11 studies and found significant health benefits for COPD patients who quit smoking. These patients showed improved lung function (FEV1% increased by 6.72, FEV1/FVC by 6.82), greater exercise capacity (6-MWT increased by 64.46), and better oxygen levels (1.96 higher). Additionally, smoking cessation reduced the risk of death (RR = 0.75). This study is credible as it synthesizes high-quality research, making it highly generalizable.

    Effectiveness of Structured Smoking Cessation Programs

    Han et al. (2023) evaluated structured smoking cessation programs that combine behavioral counseling, pharmacotherapy, and pulmonary rehabilitation. The study found that using nicotine replacement therapy (NRT) alongside cognitive-behavioral therapy resulted in higher quit rates compared to counseling alone. This study used a randomized controlled trial (RCT), which strengthens its reliability.

    Implementing Evidence-Based Practices

    Fu et al. (2022) examined how the Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model supports smoking cessation interventions. The study emphasized that structured programs integrating EBP models lead to improved pulmonary function and reduced disease progression in COPD patients. Given its systematic approach, this study is credible and directly applicable to nursing practice.

    Hu et al. (2021) reported a 27.6% abstinence rate among patients who attempted to quit smoking after six months. This study reinforces the importance of structured interventions in maintaining long-term smoking cessation.

    Analysis and Implications for Nursing Practice

    The collective evidence strongly supports structured smoking cessation programs over standard counseling for COPD patients.

    • Improved Lung Function: Wang et al. (2024) demonstrated that quitting smoking leads to significant improvements in lung function, exercise capacity, and oxygen levels.
    • Higher Quit Rates: Han et al. (2023) showed that structured programs with behavioral counseling and NRT lead to greater success in quitting smoking compared to minimal counseling.
    • Better Integration into Clinical Practice: Fu et al. (2022) emphasized the effectiveness of implementing evidence-based models, ensuring better long-term patient outcomes.

    These findings suggest that structured programs lead to better smoking cessation rates, improved respiratory health, and reduced COPD complications. Healthcare professionals, particularly nurses, should incorporate these structured interventions into patient care to achieve optimal results.

    Conclusion

    Smoking cessation is critical for COPD management. Structured programs that include behavioral counseling and pharmacotherapy are more effective than standard counseling alone. Patients who quit smoking experience better lung function, fewer hospitalizations, and improved quality of life.

    NURS FPX 4025 Assessment 3

    Nurses play a vital role in guiding patients through these programs, ensuring they receive the support needed to quit smoking. Implementing structured cessation programs in clinical practice can lead to better health outcomes for COPD patients, reducing disease progression and improving long-term wellness.

    References

    Alupo, P., Baluku, J., Bongomin, F., Siddharthan, T., Katagira, W., Ddungu, A., Hurst, J. R., Boven, van, Worodria, W., & Kirenga, B. J. (2024). Overcoming challenges of managing chronic obstructive pulmonary disease in low- and middle-income countries. Expert Review of Respiratory Medicine. https://doi.org/10.1080/17476348.2024.2398639
    American Lung Association (ALA). (2024). Learn about COPD | American Lung Association. Lung.org; American Lung Association. https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/learn-about-copd
    Centers for Disease Control and Prevention (CDC). (2024, June 12). COPD. Chronic Disease Indicators. https://www.cdc.gov/cdi/indicator-definitions/chronic-obstructive-pulmonary-disease.html

    NURS FPX 4025 Assessment 3

    Fu, Y., Chapman, E. J., Boland, A. C., & Bennett, M. I. (2022). Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review. Palliative Medicine, 36(5), 770–782. https://doi.org/10.1177/02692163221079697
    Gosak, L., Štiglic, G., Pruinelli, L., & Vrbnjak, D. (2024). PICOT questions and search strategies formulation: A novel approach using artificial intelligence automation. Journal of Nursing Scholarship. https://doi.org/10.1111/jnu.13036
    Han, M. K., Fu, Y., Ji, Q., Duan, X., & Fang, X. (2023). The effectiveness of theory-based smoking cessation interventions in patients with chronic obstructive pulmonary disease: A meta-analysis. BMC Public Health, 23(1). https://doi.org/10.1186/s12889-023-16441-w
    Hu, Y., Xie, J., Chang, X., Chen, J., Wang, W., Zhang, L., Zhong, R., Chen, O., Yu, X., & Zou, Y. (2021). Characteristics and predictors of abstinence among smokers of a smoking cessation clinic in Hunan China. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.615817
    Wang, Z., Qiu, Y., Ji, X., & Dong, L. (2024). Effects of smoking cessation on individuals with COPD: A systematic review and meta-analysis. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1433269